ALS Community Workshop in Washington, D.C.

Columbia Neurology amyotrophic lateral sclerosis (ALS) specialist Dr. Jinsy Andrews recently participated in the ALS Community Workshop in Washington, D.C. to provide feedback to the Food and Drug Administration (FDA) and pharmaceutical industry on therapy development and regulatory pathways for ALS, to inform the FDA’s Draft Guidance on ALS Drug Development.  Dr. Andrews was the discussion leader for the panel on clinical trial design. The workshop was live streamed and recorded for viewing here.